Zuclopenthixol dihydrochloride for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog
twitter: 5 tweeters

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 250 Mendeley

Summary Blogs Twitter Wikipedia Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Antipsychotic-induced movement disorders: integrative review

Article in Revista Ciências em Saúde (September 2022)

Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19

Article in ACS Pharmacology & Translational Science (October 2020)

Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation—an observational study including 2044 patients

Article in European Journal of Clinical Pharmacology (September 2020)